Free Trial

Haemonetics (HAE) SEC Filings & 10K Form

Haemonetics logo
$54.63 +0.29 (+0.53%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$56.25 +1.62 (+2.97%)
As of 08/29/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Haemonetics SEC Filings

DateFilerForm TypeView
08/12/2025
9:34 AM
Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
08/07/2025
5:04 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
5:08 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2025
3:20 PM
Bryant Diane M (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:23 PM
COYLE MICHAEL J (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:25 PM
Dockendorff Charles J (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:28 PM
Haemonetics (Issuer)
Johnson Lloyd Emerson (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:30 PM
Haemonetics (Issuer)
KROLL MARK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:33 PM
Haemonetics (Issuer)
Pomeroy Claire (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:36 PM
Haemonetics (Issuer)
Zane Ellen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
9:49 AM
Haemonetics (Subject)
Llorens Josep (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2025
3:21 PM
Galvin Roy (Reporting)
Haemonetics (Issuer)
Form 4/A
06/12/2025
3:51 PM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2025
3:49 PM
Haemonetics (Issuer)
Maunsell Farris Maryanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:17 PM
Haemonetics (Filer)
Form DEF 14A
06/06/2025
3:18 PM
Haemonetics (Filer)
Form DEFA14A
06/04/2025
9:06 AM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2025
3:41 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:31 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
12:16 PM
Haemonetics (Subject)
Strong Stewart W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2025
3:21 PM
Haemonetics (Filer)
Form SD
Specialized Disclosure Report  
05/21/2025
5:12 AM
Haemonetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/20/2025
4:21 PM
Galvin Roy (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:24 PM
Chan Frank (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:28 PM
Haemonetics (Issuer)
Miller Laurie A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:31 PM
Haemonetics (Issuer)
Maunsell Farris Maryanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:10 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:14 PM
DArecca James (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:17 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:15 PM
DArecca James (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:17 PM
Basil Michelle L (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
9:47 AM
Haemonetics (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SCHEDULE 13G/A
05/12/2025
9:44 AM
Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/08/2025
5:03 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2025
3:16 PM
DArecca James (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
3:24 PM
Capital Research Global Investors (Filed by)
Haemonetics (Subject)
Form SCHEDULE 13G/A
02/06/2025
5:19 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
5:20 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/14/2025
5:21 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
5:08 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
5:07 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
How “Trump’s New Dollar” Could Impact Your Wealth (Ad)

President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking and savings account… With this better, more technologically advanced dollar. President Trump himself called it a "big innovation"… And said that this new form of currency represents "American brilliance at its best."tc pixel

Click here now because Chase, Bank of America, Citigroup, Wells Fargo, and U.S. Bancorp…
11/12/2024
10:26 AM
Haemonetics (Subject)
Lingamneni Anila (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
9:41 AM
Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
5:03 AM
Haemonetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
5:11 AM
Haemonetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
3:17 PM
Galvin Roy (Reporting)
Haemonetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:18 PM
Haemonetics (Issuer)
Miller Laurie A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:20 PM
Haemonetics (Issuer)
Simon, Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:HAE) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners